- Filed
- Jan 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $12.71M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2024 | $25.92M |
| Cash And Equivalents restated | Q2 2025 · Sep 30, 2023 | $25.92M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $20.18M |
| Total Liabilities | Q2 2025 · Mar 31, 2024 | $17.11M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $60.1M |
| Total Assets | Q2 2025 · Mar 31, 2024 | $57.64M |
| Shares Diluted | Q2 2025 · Sep 30, 2023 | 35.01M sh |
| Capex | Q2 2025 · Sep 30, 2023 | $2.97K |
| Operating Cash Flow | Q2 2025 · Sep 30, 2023 | $2.48M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $38.99M |
| Stockholders Equity | Q2 2025 · Mar 31, 2023 | $35.95M |
| Eps Diluted | Q2 2025 · Sep 30, 2023 | $0.10 |
| Eps Basic | Q2 2025 · Sep 30, 2023 | $0.10 |
| Net Income | Q2 2025 · Sep 30, 2023 | $3.67M |
| Revenue | Q2 2025 · Sep 30, 2023 | $7.15M |